|
Real-time
Boerse Muenchen
08:14:15 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 196.30 EUR | -0.65% |
|
-1.28% | +32.16% |
| 07:22am | RBC Cuts Price Target on Biogen to $256 From $260, Keeps Outperform Rating | MT |
| 10-07 | AI companies run virtual drug trials, aim to improve success of human studies | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.70% | +2.73% | +3.42% | -3.79% | +10.61% | +40.91% | +110.31% | +409.79% | +1,348.07% | 1,060B | |
| +1.44% | -2.38% | -6.10% | -3.29% | +24.89% | +36.83% | +63.95% | +60.19% | +116.75% | 623B | |
| +1.75% | +3.73% | +5.81% | +6.56% | +18.76% | +16.55% | +83.05% | +144.76% | +331.21% | 480B | |
| +0.60% | -1.73% | -5.02% | +10.81% | +35.65% | +62.98% | +37.46% | +74.26% | +127.48% | 352B | |
| -1.14% | +1.75% | +1.31% | +6.03% | +8.20% | +21.90% | +41.56% | -1.53% | +47.34% | 345B | |
| -0.97% | +0.51% | +6.14% | -5.75% | +8.27% | +11.42% | +34.64% | +54.91% | +55.42% | 274B | |
| -0.91% | -1.82% | +0.12% | -16.07% | -12.57% | -5.67% | +11.05% | +35.81% | +137.04% | 249B | |
| +2.60% | -2.00% | -5.52% | +12.22% | +26.20% | +39.77% | +54.44% | +97.53% | +146.61% | 223B | |
| +1.82% | -1.48% | -2.75% | +7.69% | +19.64% | +25.75% | +96.48% | +115.51% | +95.18% | 182B | |
| -0.70% | -0.57% | -15.79% | -23.12% | -22.60% | -32.99% | -60.66% | -20.57% | +86.27% | 168B | |
| +1.82% | -1.82% | -1.58% | +16.33% | +12.45% | +6.59% | -15.48% | -34.49% | -16.57% | 160B | |
| +0.66% | -3.28% | -7.41% | -3.18% | +11.53% | +23.24% | +40.21% | +180.88% | +490.01% | 128B | |
| +0.18% | -4.33% | -10.66% | +2.98% | +10.68% | +33.68% | +5.37% | +1.17% | +7.70% | 122B | |
| -1.23% | +6.62% | +0.26% | +12.76% | +10.98% | +21.36% | +104.44% | +356.08% | +448.99% | 106B | |
| -0.54% | -2.30% | -4.39% | -5.24% | -13.66% | -15.57% | -30.38% | -15.28% | +2.57% | 96.29B | |
| -1.70% | -4.09% | -4.38% | -12.28% | -3.70% | +8.83% | +16.50% | +0.34% | -17.75% | 94.75B | |
| +4.81% | +2.03% | +34.99% | +146.31% | +566.26% | +618.65% | +89.14% | -36.49% | - | 78.44B | |
| +0.46% | -2.13% | -10.34% | +9.74% | -3.85% | +27.24% | -11.29% | +34.44% | +90.26% | 74.1B | |
| -1.48% | +2.60% | +2.49% | -0.86% | +12.52% | +14.91% | -11.03% | -26.01% | +41.56% | 68.2B | |
| Average | -0.38% | -0.60% | -1.02% | +8.31% | +37.91% | +50.34% | +34.72% | +75.33% | +196.56% | 257.04B | |
| Weighted average by Cap. | -0.27% | -0.20% | -0.52% | +2.46% | +21.53% | +35.83% | +56.17% | +139.68% | +406.21% |
- Stock Market
- Stocks
- BIIB Stock
- IDP Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
